Synthesis of phosphate-substituted near-infrared dyes for photoacoustic imaging and photothermal therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Theranostic fluorescent probes10.1021/acs.chemrev.3c00778 ↗
2. Near-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy10.1016/j.nantod.2020.101073 ↗
3. Carrier-free supramolecular nanomedicines assembled by small-molecule therapeutics for cancer treatment10.1016/j.cclet.2022.107827 ↗
4. Mitochondria-targeted nanotheranostic: harnessing single-laser-activated dual phototherapeutic processing for hypoxic tumor treatment10.1016/j.matt.2021.05.022 ↗
5. Finely tunable NIR‐II organic scaffolds for fluorescence/photoacoustic duplex imaging–guided noninvasive photothermal therapy of glioblastoma
6. Nanoparticulation of prodrug into medicines for cancer therapy10.1002/advs.202101454 ↗
7. Nanoparticle‐Based photothermal therapy for breast cancer noninvasive treatment
8. Near-infrared small molecular fluorescent dyes for photothermal therapy10.1016/j.cclet.2019.02.003 ↗
9. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
10. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine10.1021/acsnano.3c00891 ↗
11. Organic molecule-based photothermal agents: an expanding photothermal therapy universe10.1039/C7CS00522A ↗
12. Bacteria‐assisted selective photothermal therapy for precise tumor inhibition10.1002/adfm.201904093 ↗
13. Nanomaterials as photothermal therapeutic agents10.1016/j.pmatsci.2018.07.005 ↗
14. Exfoliated FePS3 nanosheets for T1-weighted magnetic resonance imaging-guided near-infrared photothermal therapy in vivo10.1007/s40843-021-1633-5 ↗
15. Ultrathin two‐dimensional plasmonic PtAg nanosheets for broadband phototheranostics in both NIR‐I and NIR‐II biowindows10.1002/advs.202100386 ↗
16. Photothermal therapy10.1016/j.jconrel.2020.06.032 ↗
17. Gold nanoparticle based photothermal therapy: development and application for effective cancer treatment
18. Organic semiconducting macromolecular dyes for NIR‐II photoacoustic imaging and photothermal therapy10.1002/adfm.202104650 ↗
19. Design and functionalization of the NIR-responsive photothermal semiconductor nanomaterials for cancer theranostics10.1021/acs.accounts.7b00294 ↗
20. Diketopyrrolopyrrole‐derived organic small molecular dyes for tumor phototheranostics10.1016/j.cclet.2021.10.054 ↗
21. Insights into the photothermal conversion of 2D MXene nanomaterials: synthesis, mechanism, and applications
22. Renal‐clearable molecular semiconductor for second near‐infrared fluorescence imaging of kidney dysfunction10.1002/anie.201909560 ↗
23. Renal‐Clearable ultrasmall polypyrrole nanoparticles with size‐regulated property for second near‐infrared light‐mediated photothermal therapy10.1002/adfm.202008362 ↗
24. DNA‐Templated Ag@Pd nanoclusters for NIR‐II photoacoustic imaging‐guided photothermal‐augmented nanocatalytic therapy10.1002/adhm.202300267 ↗
25. Phase and defect engineering of MoSe2 nanosheets for enhanced NIR-II photothermal immunotherapy10.1021/acs.nanolett.4c01879 ↗
26. Understanding and advancement in gold nanoparticle targeted photothermal therapy of cancer
27. D-A-D-structured boron-dipyrromethene with aggregation-induced enhanced phototherapeutic efficiency for near-infrared fluorescent and photoacoustic imaging-guided synergistic photodynamic and photothermal cancer therapy10.1016/j.cclet.2023.109452 ↗
28. Polymer‐Based therapeutic nanoagents for photothermal‐enhanced combination cancer therapy10.1002/sstr.202100110 ↗
29. Water-soluble small organic fluorophores for oncological theragnostic applications: progress and development10.1007/s41061-024-00458-9 ↗
30. Xanthene, cyanine, oxazine and BODIPY: the four pillars of the fluorophore empire for super-resolution bioimaging10.1039/D2CS00905F ↗
31. Development of probes with high signal-to-noise ratios based on the facile modification of xanthene dyes for imaging peroxynitrite during the liver ischemia/reperfusion process10.1021/acs.analchem.2c01496 ↗
32. New design strategy toward NIR I xanthene-based dyes10.1021/acs.joc.0c01242 ↗
33. Xanthene-Based NIR-II dyes for in vivo dynamic imaging of blood circulation10.1021/jacs.1c07711 ↗
34. PONy dyes: direct addition of P(III) nucleophiles to organic fluorophores10.1021/acs.orglett.8b00270 ↗
35. Rational design of a meso phosphate-substituted pyronin as a type I photosensitizer for photodynamic therapy10.1039/D2CC02124B ↗
36. A chiral fluorescent probe for molecular recognition of basic amino acids in solutions and cells10.1016/j.cclet.2024.109862 ↗
37. A detailed insight into anion sensing based on intramolecular charge transfer (ICT) mechanism: a comprehensive review of the years 2016 to 202110.1016/j.ccr.2021.214167 ↗
38. Structural and process controls of AIEgens for NIR-II theranostics10.1039/D0SC02911D ↗
39. Self-immolative photosensitizers for self-reported cancer phototheranostics10.1021/jacs.3c01666 ↗
40. A phosphorus phthalocyanine formulation with intense absorbance at 1000 nm for deep optical imaging10.7150/thno.14555 ↗